HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michal Kielbik Selected Research

Ovarian Neoplasms (Ovarian Cancer)

3/2024Snail transcription factors - Characteristics, regulation and molecular targets relevant in vital cellular activities of ovarian cancer cells.
11/2023Snail transcription factors as key regulators of chemoresistance, stemness and metastasis of ovarian cancer cells.
11/2022E-Cadherin Expression in Relation to Clinicopathological Parameters and Survival of Patients with Epithelial Ovarian Cancer.
12/2021The implication of IL-6 in the invasiveness and chemoresistance of ovarian cancer cells. Systematic review of its potential role as a biomarker in ovarian cancer patients.
11/2021Calreticulin-Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients.
1/2021Impact of Selected Signaling Proteins on SNAIL 1 and SNAIL 2 Expression in Ovarian Cancer Cell Lines in Relation to Cells' Cisplatin Resistance and EMT Markers Level.
9/2020MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance.
4/2019The Potential Role of iNOS in Ovarian Cancer Progression and Chemoresistance.
4/2018Cisplatin-induced ERK1/2 activity promotes G1 to S phase progression which leads to chemoresistance of ovarian cancer cells.
1/2017Secretion of cytokines and heat shock protein (HspA1A) by ovarian cancer cells depending on the tumor type and stage of disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michal Kielbik Research Topics

Disease

15Ovarian Neoplasms (Ovarian Cancer)
03/2024 - 01/2012
12Neoplasms (Cancer)
11/2023 - 01/2012
4Neoplasm Metastasis (Metastasis)
11/2023 - 11/2014
4Infections
01/2019 - 01/2013
3Ovarian Epithelial Carcinoma
03/2024 - 09/2020
1Colorectal Neoplasms (Colorectal Cancer)
12/2022
1Carcinoma (Carcinomatosis)
11/2022
1Ascites
12/2021
1Necrosis
12/2020
1Breast Neoplasms (Breast Cancer)
09/2020
1Tuberculosis (Tuberculoses)
01/2019
1Drug-Related Side Effects and Adverse Reactions
04/2018

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
11/2023 - 01/2012
5Cisplatin (Platino)FDA LinkGeneric
01/2021 - 01/2015
4CytokinesIBA
12/2021 - 01/2017
4Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019 - 11/2014
41- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazeneIBA
10/2016 - 11/2013
3Cadherins (E-Cadherin)IBA
11/2022 - 09/2020
3Nitric Oxide DonorsIBA
10/2016 - 11/2013
2Snail Family Transcription FactorsIBA
03/2024 - 11/2023
2Transcription Factors (Transcription Factor)IBA
03/2024 - 11/2023
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2019
2AntigensIBA
01/2022 - 11/2021
2Biomarkers (Surrogate Marker)IBA
12/2021 - 11/2021
2Interleukin-2 (IL2)IBA
12/2020 - 01/2012
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2017 - 11/2014
2Interleukin-10 (Interleukin 10)IBA
01/2017 - 02/2013
2spermine nitric oxide complexIBA
10/2016 - 01/2015
2SpermineIBA
11/2014 - 11/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2013 - 01/2013
1PlatinumIBA
11/2023
1neuromedin UIBA
12/2022
1Indicators and Reagents (Reagents)IBA
11/2022
1Interleukin-6 (Interleukin 6)IBA
12/2021
1ChemokinesIBA
11/2021
1CalreticulinIBA
11/2021
1InterleukinsIBA
12/2020
1InterferonsIBA
12/2020
1Interleukin-12 (IL 12)IBA
12/2020
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
12/2020
1Formaldehyde (Formol)FDA Link
09/2020
1MicroRNAs (MicroRNA)IBA
09/2020
1ParaffinIBA
09/2020
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2019
1Messenger RNA (mRNA)IBA
01/2019
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
04/2018
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2017
1Adenosine Triphosphate (ATP)IBA
10/2016
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2015
1Cytostatic AgentsIBA
01/2015
1Metalloproteases (Metalloproteinases)IBA
11/2014
1Matrix Metalloproteinases (MMPs)IBA
11/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2014
1CarbonIBA
02/2013
1CholesterolIBA
02/2013
1EnzymesIBA
02/2013
1ImmunosorbentsIBA
02/2013

Therapy/Procedure

7Therapeutics
11/2023 - 11/2014
1Drug Therapy (Chemotherapy)
12/2021
1Photochemotherapy (Photodynamic Therapy)
11/2021
1Radiotherapy
11/2021